NexgenRx Announces Second Quarter Results with Significant Revenue Growth and Positive EBITDA
TORONTO, ON / ACCESS Newswire / August 12, 2025 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2025, with quarterly revenue growth of $349,043 to $4,346,416 ($8,897,146 YTD) and quarterly EBITDA of $627,631. The Company achieved significant growth in revenue of $349,043 […]